Preclinical studies of mesenchymal stem cell (MSC) administration in chronic obstructive pulmonary disease (COPD): A systematic review and meta-analysis

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Liu, Xiangde ^a   Fang, Qiuhong ^b   Kim, Huijung ^c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c Wonkwang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE ELASTASE; PROSTAGLANDIN E2; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HUMAN; LUNG COMPLIANCE; LUNG INJURY; MESENCHYMAL STEM CELL TRANSPLANTATION; META ANALYSIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATIENT SAFETY; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UPREGULATION; VITAL CAPACITY; ANIMAL; CYTOLOGY; MESENCHYMAL STROMA CELL; PRECLINICAL STUDY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ANIMALS; DRUG EVALUATION, PRECLINICAL; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84975489208     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0157099     Document Type: Review

References (59)

1. Armstrong L, Lako M, Buckley N, Lappin TR, Murphy MJ, Nolta JA, et al. Editorial: Our top 10 developments in stem cell biology over the last 30 years. Stem Cells. 2012; 30(1):2-9. doi: 10.1002/stem.1007 PMID: 22162299.
2. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol. 2007; 213(2):341-7. doi: 10.1002/jcp.21200 PMID: 17620285.
3. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006; 24(5):1294-301. doi: 10.1634/stemcells.2005-0342 PMID: 16410387.
4. Minino AM. Death in the United States, 2009. NCHS Data Brief. 2011;(64: ):1-8. PMID: 22142873.
5. Kochanek KD, Xu J, Murphy SL, Minino AM, Kung HC. Deaths: preliminary data for 2009. Natl Vital Stat Rep. 2011; 59(4):1-51. PMID: 25073815.
6. Prockop DJ, Oh JY. Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther. 2012; 20(1):14-20. doi: 10.1038/mt.2011.211 PMID: 22008910; PubMed Central PMCID: PMCPMC3255583.
7. Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol. 2012; 12(5):383-96. doi: 10.1038/nri3209 PMID: 22531326.
8. Antunes MA, Abreu SC, Cruz FF, Teixeira AC, Lopes-Pacheco M, Bandeira E, et al. Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema. Respir Res. 2014; 15:118. doi: 10.1186/s12931-014-0118-x PMID: 25272959; PubMed Central PMCID: PMCPMC4189723.
9. Zhao Y, Xu A, Xu Q, Zhao W, Li D, Fang X, et al. Bone marrow mesenchymal stem cell transplantation for treatment of emphysemic rats. Int J Clin Exp Med. 2014; 7(4):968-72. PMID: 24955169; PubMed Central PMCID: PMCPMC4057848.
10. Chen YB, Lan YW, Chen LG, Huang TT, Choo KB, Cheng WT, et al. Mesenchymal stem cell-based HSP70 promoter-driven VEGFA induction by resveratrol alleviates elastase-induced emphysema in a mouse model. Cell Stress Chaperones. 2015; 20(6):979-89. doi: 10.1007/s12192-015-0627-7 PMID: 26243699; PubMed Central PMCID: PMCPMC4595438.
11. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A. 2003; 100(14):8407-11. doi: 10.1073/pnas.1432929100 PMID: 12815096; PubMed Central PMCID: PMCPMC166242.
12. Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, Ilancheran S, et al. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol. 2009; 175(1):303-13. doi: 10.2353/ajpath.2009.080629 PMID: 19497992; PubMed Central PMCID: PMCPMC2708816.
13. Tropea KA, Leder E, Aslam M, Lau AN, Raiser DM, Lee JH, et al. Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2012; 302(9):L829-37. doi: 10.1152/ajplung.00347.2011 PMID: 22328358; PubMed Central PMCID: PMCPMC3362163.
14. Aslam M, Baveja R, Liang OD, Fernandez-Gonzalez A, Lee C, Mitsialis SA, et al. Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med. 2009; 180(11):1122-30. doi: 10.1164/rccm.200902-0242OC PMID: 19713447; PubMed Central PMCID: PMCPMC2784417.
15. Curley GF, Hayes M, Ansari B, Shaw G, Ryan A, Barry F, et al. Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat. Thorax. 2012; 67(6):496-501. doi: 10.1136/thoraxjnl-2011-201059 PMID: 22106021.
16. Krasnodembskaya A, Samarani G, Song Y, Zhuo H, Su X, Lee JW, et al. Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes. Am J Physiol Lung Cell Mol Physiol. 2012; 302(10):L1003-13. doi: 10.1152/ajplung.00180.2011 PMID: 22427530; PubMed Central PMCID: PMCPMC3362255.
17. Gupta N, Krasnodembskaya A, Kapetanaki M, Mouded M, Tan X, Serikov V, et al. Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia. Thorax. 2012; 67(6):533-9. doi: 10.1136/thoraxjnl-2011-201176 PMID: 22250097; PubMed Central PMCID: PMCPMC3358432.
18. Weiss DJ, Casaburi R, Flannery R, LeRoux-Williams M, Tashkin DP. A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest. 2013; 143(6):1590-8. doi: 10.1378/chest.12-2094 PMID: 23172272.
19. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009; 62(10):1006-12. doi: 10.1016/j.jclinepi.2009.06.005 PMID: 19631508.
20. Higgins J, Thompson S, Deeks J, Altman D. Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy. 2002; 7(1):51-61. PMID: 11822262.
21. Schweitzer KS, Johnstone BH, Garrison J, Rush NI, Cooper S, Traktuev DO, et al. Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking. Am J Respir Crit Care Med. 2011; 183(2):215-25. doi: 10.1164/rccm.201001-0126OC PMID: 20709815; PubMed Central PMCID: PMCPMC3040390.
22. Li X, Zhang Y, Yeung SC, Liang Y, Liang X, Ding Y, et al. Mitochondrial transfer of induced pluripotent stem cell-derived mesenchymal stem cells to airway epithelial cells attenuates cigarette smoke-induced damage. Am J Respir Cell Mol Biol. 2014; 51(3):455-65. doi: 10.1165/rcmb.2013-0529OC PMID: 24738760.
23. Kim YS, Kim JY, Huh JW, Lee SW, Choi SJ, Oh YM. The Therapeutic Effects of Optimal Dose of Mesenchymal Stem Cells in a Murine Model of an Elastase Induced-Emphysema. Tuberc Respir Dis (Seoul). 2015; 78(3):239-45. doi: 10.4046/trd.2015.78.3.239 PMID: 26175778; PubMed Central PMCID: PMCPMC4499592.
24. Peron JP, de Brito AA, Pelatti M, Brandao WN, Vitoretti LB, Greiffo FR, et al. Human Tubal-Derived Mesenchymal Stromal Cells Associated with Low Level Laser Therapy Significantly Reduces Cigarette Smoke-Induced COPD in C57BL/6 mice. PLoS One. 2015; 10(8):e0136942. doi: 10.1371/journal.pone.0136942 PMID: 26322981; PubMed Central PMCID: PMCPMC4554986.
25. Zhen G, Liu H, Gu N, Zhang H, Xu Y, Zhang Z. Mesenchymal stem cells transplantation protects against rat pulmonary emphysema. Front Biosci. 2008; 13:3415-22. PMID: 18508443.
26. Zhen G, Xue Z, Zhao J, Gu N, Tang Z, Xu Y, et al. Mesenchymal stem cell transplantation increases expression of vascular endothelial growth factor in papain-induced emphysematous lungs and inhibits apoptosis of lung cells. Cytotherapy. 2010; 12(5):605-14. doi: 10.3109/14653241003745888 PMID: 20429787.
27. Huh JW, Kim SY, Lee JH, Lee JS, Van Ta Q, Kim M, et al. Bone marrow cells repair cigarette smoke-induced emphysema in rats. Am J Physiol Lung Cell Mol Physiol. 2011; 301(3):L255-66. doi: 10.1152/ajplung.00253.2010 PMID: 21622846.
28. Guan XJ, Song L, Han FF, Cui ZL, Chen X, Guo XJ, et al. Mesenchymal stem cells protect cigarette smoke-damaged lung and pulmonary function partly via VEGF-VEGF receptors. J Cell Biochem. 2013; 114(2):323-35. doi: 10.1002/jcb.24377 PMID: 22949406.
29. Zhang WG, He L, Shi XM, Wu SS, Zhang B, Mei L, et al. Regulation of transplanted mesenchymal stem cells by the lung progenitor niche in rats with chronic obstructive pulmonary disease. Respir Res. 2014; 15:33. doi: 10.1186/1465-9921-15-33 PMID: 24661402; PubMed Central PMCID: PMCPMC3987841.
30. Gu W, Song L, Li XM, Wang D, Guo XJ, Xu WG. Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways. Sci Rep. 2015; 5:8733. doi: 10.1038/srep08733 PMID: 25736434; PubMed Central PMCID: PMCPMC4348625.
31. Yuhgetsu H, Ohno Y, Funaguchi N, Asai T, Sawada M, Takemura G, et al. Beneficial effects of autologous bone marrow mononuclear cell transplantation against elastase-induced emphysema in rabbits. Exp Lung Res. 2006; 32(9):413-26. doi: 10.1080/01902140601047633 PMID: 17162649.
32. Shigemura N, Okumura M, Mizuno S, Imanishi Y, Nakamura T, Sawa Y. Autologous transplantation of adipose tissue-derived stromal cells ameliorates pulmonary emphysema. Am J Transplant. 2006; 6(11):2592-600. doi: 10.1111/j.1600-6143.2006.01522.x PMID: 17049053.
33. Furuya N, Takenaga M, Ohta Y, Tokura Y, Hamaguchi A, Sakamaki A, et al. Cell therapy with adipose tissue-derived stem/stromal cells for elastase-induced pulmonary emphysema in rats. Regen Med. 2012; 7(4):503-12. doi: 10.2217/rme.12.25 PMID: 22817624.
34. Feizpour A, Boskabady MH, Ghorbani A. Adipose-derived stromal cell therapy affects lung inflammation and tracheal responsiveness in guinea pig model of COPD. PLoS One. 2014; 9(10):e108974. doi: 10.1371/journal.pone.0108974 PMID: 25330334; PubMed Central PMCID: PMCPMC4203716.
35. Ghorbani A, Feizpour A, Hashemzahi M, Gholami L, Hosseini M, Soukhtanloo M, et al. The effect of adipose derived stromal cells on oxidative stress level, lung emphysema and white blood cells of guinea pigs model of chronic obstructive pulmonary disease. Daru. 2014; 22(1):26. doi: 10.1186/2008-2231-22-26 PMID: 24495506; PubMed Central PMCID: PMCPMC3922605.
36. Li Y, Gu C, Xu W, Yan J, Xia Y, Ma Y, et al. Therapeutic effects of amniotic fluid-derived mesenchymal stromal cells on lung injury in rats with emphysema. Respir Res. 2014; 15:120. doi: 10.1186/s12931-014-0120-3 PMID: 25319435; PubMed Central PMCID: PMCPMC4201761.
37. Katsha AM, Ohkouchi S, Xin H, Kanehira M, Sun R, Nukiwa T, et al. Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model. Mol Ther. 2011; 19(1):196-203. doi: 10.1038/mt.2010.192 PMID: 20842104; PubMed Central PMCID: PMCPMC3017437.
38. Tibboel J, Keijzer R, Reiss I, de Jongste JC, Post M. Intravenous and intratracheal mesenchymal stromal cell injection in a mouse model of pulmonary emphysema. COPD. 2014; 11(3):310-8. doi: 10. 3109/15412555.2013.854322 PMID: 24295402; PubMed Central PMCID: PMCPMC4046870.
39. Rothstein HR, Sutton AJ, Borenstein M. Publication Bias in Meta-Analysis. In: Rothstein H.R.; Sutton AB, M, editor. Publication Bias in Meta-Analysis - Prevention, Assessment and Adjustments. John Wiley & Sons, Ltd: Wiley; 2005. p. 1-7.
40. Mulhall AM, Droege CA, Ernst NE, Panos RJ, Zafar MA. Phosphodiesterase 4 inhibitors for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs. Expert Opin Investig Drugs. 2015:1-15. doi: 10.1517/13543784.2015.1094054 PMID: 26419847.
41. Caplan AI. Why are MSCs therapeutic? New data: new insight. J Pathol. 2009; 217(2):318-24. doi: 10.1002/path.2469 PMID: 19023885.
42. Bianco P, Cao X, Frenette PS, Mao JJ, Robey PG, Simmons PJ, et al. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med. 2013; 19(1):35-42. doi: 10.1038/nm.3028 PMID: 23296015; PubMed Central PMCID: PMCPMC3998103.
43. Griffin MD, Ryan AE, Alagesan S, Lohan P, Treacy O, Ritter T. Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far? Immunol Cell Biol. 2013; 91(1):40-51. doi: 10.1038/icb.2012.67 PMID: 23207278.
44. Rennard SI, Wachenfeldt K. Rationale and emerging approaches for targeting lung repair and regeneration in the treatment of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2011; 8(4):368-75. doi: 10.1513/pats.201102-019RM PMID: 21816994.
45. Ribeiro-Paes JT, Bilaqui A, Greco OT, Ruiz MA, Marcelino MY, Stessuk T, et al. Unicentric study of cell therapy in chronic obstructive pulmonary disease/pulmonary emphysema. Int J Chron Obstruct Pulmon Dis. 2011; 6:63-71. doi: 10.2147/COPD.S15292 PMID: 21311694; PubMed Central PMCID: PMCPMC3034284.
46. Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood. 2003; 101(8):2999-3001. doi: 10.1182/blood-2002-06-1830 PMID: 12480709.
47. Park BN, Shim W, Lee G, Bang OY, An YS, Yoon JK, et al. Early distribution of intravenously injected mesenchymal stem cells in rats with acute brain trauma evaluated by (99m)Tc-HMPAO labeling. Nucl Med Biol. 2011; 38(8):1175-82. doi: 10.1016/j.nucmedbio.2011.05.009 PMID: 21831649.
48. Jasmin, Jelicks LA, Koba W, Tanowitz HB, Mendez-Otero R, Campos de Carvalho AC, et al. Mesenchymal bone marrow cell therapy in a mouse model of chagas disease. Where do the cells go? PLoS Negl Trop Dis. 2012; 6(12):e1971. doi: 10.1371/journal.pntd.0001971 PMID: 23272265; PubMed Central PMCID: PMCPMC3521704.
49. von Bahr L, Batsis I, Moll G, Hagg M, Szakos A, Sundberg B, et al. Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation. Stem Cells. 2012; 30(7):1575-8. doi: 10.1002/stem.1118 PMID: 22553154.
50. Choi H, Lee RH, Bazhanov N, Oh JY, Prockop DJ. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-kappaB signaling in resident macrophages. Blood. 2011; 118(2):330-8. doi: 10.1182/blood-2010-12-327353 PMID: 21551236; PubMed Central PMCID: PMCPMC3138686.
51. English K, Ryan JM, Tobin L, Murphy MJ, Barry FP, Mahon BP. Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. Clin Exp Immunol. 2009; 156(1):149-60. doi: 10.1111/j.1365-2249.2009.03874.x PMID: 19210524; PubMed Central PMCID: PMCPMC2673753.
52. Ge W, Jiang J, Arp J, Liu W, Garcia B, Wang H. Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression. Transplantation. 2010; 90(12):1312-20. doi: 10.1097/TP.0b013e3181fed001 PMID: 21042238.
53. Kavanagh H, Mahon BP. Allogeneic mesenchymal stem cells prevent allergic airway inflammation by inducing murine regulatory T cells. Allergy. 2011; 66(4):523-31. doi: 10.1111/j.1398-9995.2010.02509.x PMID: 21091718.
54. Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med. 2009; 15(1):42-9. doi: 10.1038/nm.1905 PMID: 19098906; PubMed Central PMCID: PMCPMC2706487.
55. Nemeth K, Keane-Myers A, Brown JM, Metcalfe DD, Gorham JD, Bundoc VG, et al. Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc Natl Acad Sci U S A. 2010; 107(12):5652-7. doi: 10.1073/pnas.0910720107 PMID: 20231466; PubMed Central PMCID: PMCPMC2851758.
56. Ghannam S, Pene J, Moquet-Torcy G, Jorgensen C, Yssel H. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. J Immunol. 2010; 185(1):302-12. doi: 10.4049/jimmunol.0902007 PMID: 20511548.
57. Duffy MM, Pindjakova J, Hanley SA, McCarthy C, Weidhofer GA, Sweeney EM, et al. Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor. Eur J Immunol. 2011; 41(10):2840-51. doi: 10.1002/eji.201141499 PMID: 21710489.
58. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001; 54(10):1046-55. PMID: 11576817.
59. Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011; 343:d4002. doi: 10.1136/bmj.d4002 PMID: 21784880.